Reliq Health Technologies, Inc. Announces New Contract in Nigeria to Provide iUGO Care and iUGO Voice to Chronic Disease Patients

Rhea-AI Summary

Reliq Health Technologies Inc. has announced a new contract with a regional clinic in Nigeria to implement its iUGO Care Remote Patient Monitoring and related platforms for chronic disease management. This partnership aims to address the healthcare challenges faced by over 4 million diabetics and 8 million hypertensive patients in Nigeria. CEO Dr. Lisa Crossley highlighted the growing need for accessible healthcare solutions in the region, emphasizing Reliq's capacity to enhance health outcomes through its technology. Onboarding is expected to begin in July 2021.

Positive

• Contract signed with a large regional clinic in Nigeria for iUGO Care solutions.
• Addressing healthcare access for over 12 million chronic disease patients.
• Partnership with Just Heart Help enhances deployment capabilities.
• Potential to improve health outcomes and reduce healthcare costs.

Negative

• None.

HAMILTON, Ontario, June 15, 2021 (GLOBE NEWSWIRE) -- Reliq Health Technologies Inc. (TSXV:RHT or OTC:RQHTF or WKN:A2AJTB) (“Reliq” or the “Company”), a rapidly growing global telemedicine company that develops innovative Virtual Care solutions for the multi-billion dollar Healthcare market, today announced that it has signed a paying contract with a large regional clinic in Nigeria to provide its iUGO Care Remote Patient Monitoring (RPM), Chronic Care Management (CCM) and Behavioural Health Integration (BHI) modules and its iUGO Voice automated interactive voice recognition platform to their chronic disease patients.

“Nigeria has a population of over 210 Million people,” said Dr. Lisa Crossley, CEO of Reliq Health Technologies. “Over 4 Million Nigerians have diabetes and over 8 Million have hypertension. Healthcare resources in Nigeria are strained, and access to healthcare personnel, clinics and hospitals is extremely limited in rural Nigeria in particular. The rate of preventable complications resulting from chronic diseases like diabetes and hypertension is very high in this population, leading to poor health outcomes and reduced life expectancy. Working with Just Heart Help, a philanthropic organization founded by Baltimore, MD-based cardiologist Dr. Camellus Ezeugwu and Sirlyne Ezeugwu, Reliq will be able to deploy our iUGO Care and iUGO Voice solutions in Nigeria to help cost-effectively improve health outcomes and access to care for chronic disease patients. Our software’s multilingual capabilities and our track record of successful deployment in areas with very limited infrastructure and connectivity – such as Northern Ontario and rural Texas – Reliq is uniquely positioned to meet the needs of the rural and urban Nigerian population. We expect to start onboarding in July.”

Just Heart Help
Just Heart Help, Inc. was founded in 2004 by Dr. Camellus Ezeugwu and Sirlyne Ezeugwu.  Just Heart Help is involved in projects in the US, Nigeria, Zambia and Haiti.

Dr. Ezeugwu is an Interventional Cardiologist and Assistant Professor of Medicine at The Johns Hopkins University School of Medicine, the Medical Director at Just Heart Cardiovascular Group in Baltimore, MD and a member of Reliq’s Medical Advisory Board.

Reliq Health
Reliq Health Technologies is a rapidly growing global telemedicine company that specializes in developing innovative Virtual Care solutions for the multi-billion dollar Healthcare market. Reliq’s powerful iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT, on the OTC as RQHTF and on the WKN as A2AJTB.

ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director

For further information please contact:

Company Contact
Investor Relations at ir@reliqhealth.com

US Investor Relations Contact
Investor Relations
Lytham Partners, LLC
Ben Shamsian
New York | Phoenix
646-829-9701
shamsian@lythampartners.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Cautionary Statements Regarding Forward Looking Information

Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are "forward-looking statements".

We caution you that such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.

Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.

Reliq Health Technologies Inc. (the "Company") does not intend and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company's historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.

SOURCE: Reliq Health Technologies Inc.

FAQ

What is Reliq Health Technologies' new contract in Nigeria about?

Reliq Health has signed a contract to provide its iUGO Care Remote Patient Monitoring and related services to a clinic in Nigeria for chronic disease management.

How many patients in Nigeria are affected by diabetes and hypertension according to Reliq?

Over 4 million Nigerians have diabetes and over 8 million have hypertension.

When is Reliq expected to start onboarding in Nigeria?

Onboarding is expected to begin in July 2021.

What is the significance of the partnership with Just Heart Help?

The partnership with Just Heart Help aims to improve healthcare access and outcomes for chronic disease patients in Nigeria.

What technology is Reliq Health using in Nigeria?

Reliq Health is deploying its iUGO Care Remote Patient Monitoring and iUGO Voice platforms in Nigeria.